Trial Profile
A Multi-Center, Pediatric, Open-Label, Preference Study of Desloratadine 2.5 mg Reditab (SCH34117) and Zyrtec 5.0 mg Chewable Tablet Medications
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 11 Feb 2022
Price :
$35
*
At a glance
- Drugs Desloratadine (Primary) ; Cetirizine
- Indications Hypersensitivity
- Focus Therapeutic Use
- Sponsors Organon
- 06 Nov 2008 New trial record.